is a complete pelvic floor therapy system designed to treat female
urinary incontinence in a physician's office. Studies have proven this non-invasive and painless therapy to be an effective first
line conservative therapy.
possible future roles of Extracorporeal Magnetic Innervation (ExMI) technology.
It's not just a
conservative incontinence therapy anymore.
Although highly advanced, an ExMI session is actually quite simple...
and it's prescribed by you. A typical therapy session lasts for 20 to 30
minutes, but you define the logistics of the prescription. Patients
sit fully clothed in the treatment chair, while the pulsing magnetic
fields generated by the therapy head penetrate the tissues of
the perineum, simultaneously reaching all nerves and muscles of
the pelvic floor. These muscles contract in response to each pulse.
The frequency and strength of contractions can be set to the exact
protocol prescribed by the physician to build strength and endurance
and improve circulation in the muscles.
- New Testimonials in System
- Stats Update in Clinical
re-launches Insights In Innervation
2004 - Your source for the latest updates on ExMI technology and
Neotonus, Inc. will reappear on our website in July 2004, free of
charge. Check the
Neotonus website in early July and every month thereafter for
your free digital copy of our monthly newsletter.
NeoControl receives category 3 CPT Code from AMA
- NeoControl was given 0029T as its code (Level 3 CPT) in December 2001.
Neotonus, Inc. is in constant correspondence with the American
Medical Association and American Urological Association to obtain a
Level 1 code.
Pelvic Floor Stimulation has been included in Empire Blue Cross
Blue Shield's Policy Statement. See our press
room for the formal policy statement.
is no longer considered investigational. It is an accepted
conservative therapy to precede surgery in the treatment of urinary
Chair featured on Good Morning America
30, 2001 - Today on Good Morning America, Dr. Jennifer Berman and
Dr. Laura Berman discussed female urinary incontinence (UI). Dr.
Jennifer Berman highlighted NeoControl therapy as an effective treatment
option for UI. Dr. Berman told anchor Diane Sawyer, "(the therapy)
works...and is supported by well controlled clinical studies." Noting
that many women with urinary incontinence abstain from sexual relations,
Dr. Laura Berman recommended that women seek help for their incontinence
and discuss their condition with their partners. Dr. Jennifer Berman
and Dr. Shlomo Raz of UCLA are currently conducting a clinical trial
studying the effect of ExMI on female sexual dysfunction.